Latest Financials News

Starpharma has secured a $5.5 million upfront payment from Genentech as part of a new collaboration to develop dendrimer-drug conjugates targeting cancer therapies. The partnership includes potential milestone payments exceeding half a billion dollars and tiered royalties.

Winchester Energy has successfully completed drilling the JVU-5 well at its Varn waterflood project in Texas, confirming promising oil and gas shows and setting the stage for production ramp-up.

MAAS Group Holdings reported a 6% rise in FY25 underlying EBITDA to $219.4 million, driven by strong construction materials growth and strategic acquisitions. The company projects FY26 EBITDA between $240 million and $270 million, underpinned by renewable energy projects and a robust capital recycling program.

Maas Group Holdings delivered a record $219.4 million Underlying EBITDA in FY25, driven by strategic acquisitions and disciplined capital recycling. The company projects further growth with FY26 EBITDA guidance between $240 million and $270 million amid stable market conditions and expanding renewable energy projects.

Aeris Resources reported solid Q1 FY26 results with steady copper and gold production, disciplined cost management, and advancing divestment plans for non-core assets.

Aeris Resources reported steady Q1 FY26 production with 10.3kt copper equivalent at AISC of A$4.64/lb, alongside significant growth capital investment and promising exploration results.

Dateline Resources’ Managing Director Stephen Baghdadi has increased his personal investment by exercising 13.86 million options, reinforcing confidence in the Colosseum Gold and Rare Earth Elements Project as feasibility studies progress.

MedAdvisor Solutions reported a steep 52.8% revenue decline in Q1 FY26, impacted by US regulatory pressures and vaccine program delays, while embarking on a strategic transformation to restore growth.

Jupiter Energy reported steady oil sales of US$1.65 million in Q3 2025, all through domestic channels, while nearing completion of a key gas pipeline integration that promises operational efficiencies.

MedAdvisor reports a sharp 53% drop in 1Q FY26 revenue driven by U.S. regulatory and sector challenges, while advancing a major platform transformation and selling its ANZ business to emerge debt-free.

Arrow Minerals Limited has suspended all field activities in Guinea due to unresolved questions over exploration permit renewals, maintaining a cautious financial stance while awaiting government clarity.

Vitasora Health has received $2.43 million from a cornerstone investor, advancing its $11 million capital raise and reinforcing its path to profitability by Q4 FY2026. The company’s expanding US partnerships and technology investments signal growing market confidence.